Recap: Bicycle Therapeutics Q3 Earnings

Bicycle Therapeutics BCYC reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Bicycle Therapeutics missed estimated earnings by 7.87%, reporting an EPS of $-0.96 versus an estimate of $-0.89.

Revenue was down $1.29 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.05 which was followed by a 3.31% increase in the share price the next day.

Here's a look at Bicycle Therapeutics's past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.85 -0.68 -0.61 -0.61
EPS Actual -0.90 -0.93 -0.63 -0.59
Revenue Estimate 3.71M 4.41M 5.31M 4.43M
Revenue Actual 4.38M 3.86M 3.77M 4.33M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Bicycle Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

BCYC Logo
BCYCBicycle Therapeutics PLC
$8.37-3.79%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
6.23
Growth
Not Available
Quality
Not Available
Value
32.06
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...